Thank you, Mr. Chair.
Dr. Pai, I take your point with respect to domestic capacity. I know that the Government of Canada made a SIF grant of $173 million for that purpose to a company called Medicago. The problem is that they developed a vaccine, the Covifenz vaccine—and you may be aware of this issue—but when they applied to the World Health Organization for an emergency permit, they were denied.
They were denied because the Philip Morris tobacco company has a major stake in Medicago, and the World Health Organization has a policy that they won't do business with tobacco companies. Do you see this as a failure of due diligence on the part of the Government of Canada and a misstep in terms of trying not only to develop domestic capacity but to meet our COVAX obligations as well?